Your gateway to driving AI-enabled impact.
We help life sciences organizations transform fragmented data silos into actionable insights that drive measurable impact across the product lifecycle, from clinical to commercial. We build trusted data foundations to apply machine learning for product forecasting, provider segmentation, patient identification, and customer engagement. With data strategies grounded in Putnam’s scientific rigor and therapeutic expertise, we bring clarity to complex data, leveraging AI proprietary tools and analytics platforms to empower faster decisions and long-term brand growth.
We’re equipped with capabilities to support a wide range of data and analytics services and strategic opportunity assessments, identifying new datasets if needed to meet the business objective.
Putnam brings experience across the complex and continuously evolving health data landscape and patient tokenization ecosystems. Including with claims, genomic, lab, electronic health, sales and marketing data, to uncover pivotal moments that matter in treatment journeys.
We have a pre-built AI foundation that enables faster, smarter decision-making. Through secure architectures, and connected ecosystems, we transform structured and unstructured data into actionable insights.
A data platform that combines human expertise and AI-driven insights, so our consultants can support you with faster strategic decision making when bringing your drugs to market.
Data Gateway is our end-to-end data solution that establishes a unified dataset by integrating diverse sources of patient-level and provider-level data, addressing data gaps, and providing a comprehensive view of the competitive landscape. We utilize rigorous methodologies to create structured patient journeys, national market projection models, enhanced data quality through detailed clinical business rules backed by our strategic disease-area expertise for Commercial and Medical teams.
See how we’re helping clients solve key challenges and deliver on their ambitions.
Jump to a slide with the slide dots.
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Assessing the opportunity and investment of AI and biomarker diagnostic solutions.
The client team wanted to create a best-in-class data platform to support insights, forecasting, targeting, next generation data modeling.
As Partner and Global Data Strategy, Analytics and AI Practice Lead, Jo Ann brings over 20 years of C-level strategy and operational experience in the Healthcare field specializing in digital technology and data-driven business transformation initiatives, including: global digital and data analytics centers of excellence, enterprise and business unit AI/GenAI value programs, tech/data productization, 360 HCP customer master ecosystems, medical affairs digital innovation, sales force effectiveness platforms, M&A, and strategic partnerships with data providers, Big Tech and emerging tech companies. Jo Ann partners with clients to harness the power of their data, analytics, and AI to solve complex problems and drive sustainable business growth.
With our people at the center of innovation, we combine deep scientific expertise, strategic insight, and advanced analytics to help clients become AI-ready and deploy solutions that drive smarter, faster decisions and measurable impact.
Get the latest insights and perspectives from our experts.
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
GLP-1s are redefining cardiometabolic care. Explore key insights, trials, and whitespace from ACC 2025 with ClarityNav analysis.
ClarityNav reveals rising momentum for Lp(a) at ACC 2025, merging scientific data with digital insights to guide strategy.
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
